|
⚲
|
| Keyboard |
| TLS Beta Pte Ltd
✚
|
|
|---|---|
| CIK # | 0001673754 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| BlackRock Inc | 5.1 | ||
| Visa Inc | 2.0 | ||
| Nvidia Corp | 1.6 | ||
| Mastercard Inc | 1.6 | ||
| Alphabet Inc | 1.4 | ||
| Broadcom Inc | 1.1 | ||
| Amazon Com Inc | 1.0 | ||
| Microsoft Corp | 1.0 | ||
| Thermo Fisher Scientific Inc | 0.6 | ||
| McGraw-Hill Companies Inc | 0.6 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001673754] | |
| 3 | [0001673754] | |
| 4 | [0001673754] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akili Inc AKLI
Earnout Shares · derivative
|
2024-07-02 | Tender | 1,172,697 | ||
|
Akili Inc AKLI
Common Stock, par value $0.0001
|
2024-07-02 | Tender | 10,336,425 | ||
|
Vir Biotechnology Inc VIR
Series A-1 Preferred Stock · derivative
|
2019-10-16 | Conversion | 3,333,333 | ||
|
Vir Biotechnology Inc VIR
Common Stock
|
2019-10-16 | Buy | 500,000 | $20.00 | 10,000,000 |
|
Vir Biotechnology Inc VIR
Common Stock
|
2019-10-16 | Conversion | 3,333,333 | ||
|
Vir Biotechnology Inc VIR
Series B Preferred Stock · derivative
|
2019-10-16 | Conversion | 1,666,666 | ||
|
Vir Biotechnology Inc VIR
Common Stock
|
2019-10-16 | Conversion | 1,666,666 | ||
|
Guardant Health Inc GH
SERIES D PREFERRED STOCK · derivative
|
2018-10-09 | Conversion | 1,016,995 | ||
|
Guardant Health Inc GH
COMMON STOCK
|
2018-10-09 | Conversion | 596,012 | ||
|
Guardant Health Inc GH
COMMON STOCK
|
2018-10-09 | Conversion | 1,016,995 | ||
|
Guardant Health Inc GH
SERIES E PREFERRED STOCK · derivative
|
2018-10-09 | Conversion | 596,012 | ||
|
Q32 Bio Inc FIXX
Common Stock
|
2018-04-02 | Conversion | 989,612 | ||
|
Q32 Bio Inc FIXX
Common Stock
|
2018-04-02 | Conversion | 1,605,681 | ||
|
Q32 Bio Inc FIXX
Series A Preferred Stock · derivative
|
2018-04-02 | Conversion | 1,605,681 | ||
|
Q32 Bio Inc FIXX
Series B Preferred Stock · derivative
|
2018-04-02 | Conversion | 989,612 | ||
|
Q32 Bio Inc FIXX
Common Stock
|
2018-04-02 | Buy | 625,000 | $16.00 | 10,000,000 |
|
Intellia Therapeutics Inc NTLA
Series B Preferred Stock · derivative
|
2016-05-11 | Conversion | 490,527 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Buy | 300,000 | $18.00 | 5,400,000 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Conversion | 490,527 |